|
N4BP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.391310E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.363930E-03 |
| Normal-vs-Stage2 |
2.184600E-01 |
| Normal-vs-Stage3 |
2.26319999996338E-06 |
| Normal-vs-Stage4 |
5.220500E-03 |
| Stage1-vs-Stage2 |
4.217200E-01 |
| Stage1-vs-Stage3 |
2.944300E-02 |
| Stage1-vs-Stage4 |
6.138400E-01 |
| Stage2-vs-Stage3 |
5.038300E-02 |
| Stage2-vs-Stage4 |
3.030800E-01 |
| Stage3-vs-Stage4 |
2.962800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.417800E-04 |
| Normal-vs-AfricanAmerican |
1.104700000365E-07 |
| Normal-vs-Asian |
5.417800E-01 |
| Caucasian-vs-AfricanAmerican |
8.759000E-04 |
| Caucasian-vs-Asian |
5.985800E-01 |
| AfricanAmerican-vs-Asian |
5.560100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.212710E-04 |
| Normal-vs-Female |
2.137800E-03 |
| Male-vs-Female |
5.676800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.180500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.963500E-03 |
| Normal-vs-Age(61-80Yrs) |
8.792500E-04 |
| Normal-vs-Age(81-100Yrs) |
1.320880E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.156790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.323230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.957800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.371400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.224000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.635600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.267000E-01 |
| Normal-vs-Grade 2 |
2.095500E-03 |
| Normal-vs-Grade 3 |
3.441500E-04 |
| Normal-vs-Grade 4 |
6.800600E-04 |
| Grade 1-vs-Grade 2 |
6.449800E-01 |
| Grade 1-vs-Grade 3 |
4.772000E-01 |
| Grade 1-vs-Grade 4 |
3.265800E-01 |
| Grade 2-vs-Grade 3 |
5.161600E-01 |
| Grade 2-vs-Grade 4 |
2.451000E-01 |
| Grade 3-vs-Grade 4 |
4.755000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.980200E-02 |
| Normal-vs-ccB subtype |
1.602770E-04 |
| ccA subtype-vs-ccB subtype |
2.032100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.379600E-03 |
| Normal-vs-N1 |
2.208800E-01 |
| N0-vs-N1 |
8.543200E-01 |
|
|
